Supply Chain Intelligence

NovaBridge Biosciences Supply Chain

NBP supply chain intelligence for NovaBridge Biosciences: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

NBP ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

4Suppliers
0Customers
3Debt Items
20Related Chains

NovaBridge Biosciences Suppliers

TickerNameConfidenceEvidence
CONTRACT-MANUFACTURERS CONTRACT-MANUFACTURERS 90% We rely on third parties, including those located in China, for supply of our drug candidates, and our strategy is to outsource all manufacturing of our drug candidates and products to third parties.
CRITICAL-REAGENT-SUPPLIERS CRITICAL-REAGENT-SUPPLIERS 90% We rely on third parties, including those located in China, for supply of our drug candidates, and our strategy is to outsource all manufacturing of our drug candidates and products to third parties.
THIRD-PARTIES THIRD-PARTIES 90% We also rely on third parties, including those located in China, for supply of our drug candidates, and our strategy is to outsource all manufacturing of our drug candidates and products to third parties.
CHINA-BASED-SUPPLIERS CHINA-BASED-SUPPLIERS 80% In addition, certain Chinese biotechnology companies may become subject to trade restrictions, sanctions, other regulatory requirements, or proposed legislation by the U.S. government, which could re…

NovaBridge Biosciences Customers

No clients on recordNo downstream customers found in our database for NovaBridge Biosciences.

NovaBridge Biosciences Debt Obligations

InstrumentDescriptionConfidenceEvidence
NBP-DEBT Debt stack $3.1M 90% Market cache reports total debt of $3.1M.
NBP-DEBT-11180 Warrants outstanding: 109743000 90% xbrl warrant detail from xbrl 2021-12-31.
NBP-DEBT-11181 Xbrl Convertible 90% xbrl convertible detail from xbrl 2020-12-31.

NovaBridge Biosciences Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for NovaBridge Biosciences.

NovaBridge Biosciences Ownership

HolderNameConfidenceEvidence
NBP-OWNER-JANUS-HENDERSON-GROUP-PLC JANUS HENDERSON GROUP PLC 90% 13F overlay lists JANUS HENDERSON GROUP PLC as top holder; 49 tracked holders.

NovaBridge Biosciences Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
BEAM Beam Therapeutics Inc. 100.00 2
ALVO Alvotech 100.00 2
CYTK Cytokinetics, Incorporated 100.00 2
ALXO ALX Oncology Holdings Inc. 100.00 2
CBIO Crescent Biopharma, Inc. 100.00 2
BNR Burning Rock Biotech Limited 100.00 2
BLLN BillionToOne, Inc. 100.00 2
BLRX BioLineRx Ltd. 100.00 2
ANIK Anika Therapeutics, Inc. 100.00 2
ANL Adlai Nortye Ltd. 100.00 2
WHWK Whitehawk Therapeutics, Inc. 100.00 2
ANRO Alto Neuroscience, Inc. 100.00 2
AORT Artivion, Inc. 100.00 2
AVBP ArriVent BioPharma, Inc. 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
EMMA Emmaus Life Sciences, Inc. 100.00 2
GRAL GRAIL, Inc. 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
BNRG Brenmiller Energy Ltd 100.00 2
View NBP supply chain intel →

Explore the full interactive supply chain map for NovaBridge Biosciences.

Open NBP supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map